35% response rate in the ADP-A2M4CD8 monotherapy cohort with ~5 months median duration of response in heavily pre-treated patients across a broad range of solid tumors 50% response rate in 26 patients.
Amerykañscy eksperci: Trzecia fala pandemii zim±, wzrost liczby zgonów wiosn± tokfm.pl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tokfm.pl Daily Mail and Mail on Sunday newspapers.